Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

TGF-beta 1 and TGF-beta 2 are equipotent selective inhibitors of murine and human haemopoiesis in vitro. Primitive haemopoietic cells such as the high proliferative potential progenitor cell and the colony-forming unit (CFU)-GEMM are directly inhibited by TGF-beta whereas the more differentiated CFU-G, CFU-M and CFU-E are not. Recombinant TGF-beta 1 administered intraperitoneally or intravenously to mice selectively inhibits haemopoietic colony formation in a time- and dose-dependent manner to the same extent as seen in vitro. The progenitors are reversibly prevented from entering the cell cycle. This inhibitory action of TGF-beta functions on at least two levels: (1) down-modulation of the cell surface expression of receptors for growth stimulatory molecules and (2) interference with the intracellular signalling pathways of these molecules. In addition, expression of TGF-beta receptors is regulated during cytokine stimulation of haemopoiesis. Neoplastic B lymphocytes can proliferate by escaping from a TGF-beta-mediated autocrine inhibitory loop. Activation signals (e.g. phorbol esters) inhibit tumour cell growth by stimulating active TGF-beta production and inducing cell surface expression of TGF-beta receptors. These results indicate that TGF-beta may be useful as a bone marrow protective and/or an antitumour agent.

Original publication

DOI

10.1002/9780470514061.ch14

Type

Journal article

Journal

Ciba Found Symp

Publication Date

1991

Volume

157

Pages

212 - 227

Keywords

Animals, Antineoplastic Agents, B-Lymphocytes, Cell Cycle, Cells, Cultured, Cytokines, Down-Regulation, Drug Synergism, Granulocyte-Macrophage Colony-Stimulating Factor, Hematopoiesis, Hematopoietic Stem Cells, Humans, Immunologic Factors, Leukemia, Promyelocytic, Acute, Lymphoma, B-Cell, Mice, Neoplastic Stem Cells, Receptors, Cell Surface, Receptors, Transforming Growth Factor beta, Recombinant Proteins, Transforming Growth Factor beta, Tumor Cells, Cultured